FDA staff note deaths in Pfizer bone drug study

Category: Health

Publish Date: 09-04-2008 10:50 AM -0700

WASHINGTON (Reuters) - Osteoporosis patients who received a low dose of an experimental Pfizer Inc pill were more likely to die within five years than others who got a placebo, U.S. drug reviewers said in an analysis released on Thursday.

Continue to Original Story >